The efficacy of an embryonic stem cell-based vaccine for lung cancer prevention depends on the undifferentiated state of the stem cells is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Congressionally Directed Medical Research Programs
Grant: LC180452
National Institutes of Health
Grant: ES011564
National Institutes of Health
Grant: CA198249
National Institutes of Health
Grant: CA277314
NIEHS NIH HHS
Grant: T32 ES011564
NCI NIH HHS
Grant: R21 CA198249
NCI NIH HHS
Grant: R21 CA277314
NCI NIH HHS
Grant: R21 CA280453
National Institutes of Health
Grant: 5T32ES011564-20
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAM
National Institutes of Health
Grant: 1R21CA280453-01
A lung cancer vaccine based on exosomes of induced pluripotent stem cells
National Institutes of Health
Grant: 1R21CA198249-01
A Novel Vaccination Stratagem for Lung Cancer
National Institutes of Health
Grant: 5R21CA277314-02
A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer
National Institutes of Health
Grant: 5R01CA175003-03
Activating Bax as a therapeutic strategy for lung cancer
FWCI
0.70
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals